BOY Bodycote plc
Bodycote plc provides heat treatment and thermal processing services worldwide. It operates in Specialist Technologies and Precision Heat Treatment divisions. The company offers heat treatment services, including altering the microstructure of metals and alloys, which include steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, HIP diffusion bonding, hydrogen brazing, induction brazing, and furnace/vacuum brazing; and hot isostatic pressing (HIP) services, such as isostatic pressing and HIP supporting services, as well as Powdermet technologies. It also provides surface technologies, which are used to prolong the working life of components and protect from environmental factors, such as corrosion and abrasion. The company's surface technologies include anodising, flame and combustion spraying, high-velocity oxygen fuel coatings, plasma spray, electric arc wire, vapor phase aluminide, liquid and ceramic coatings, and thermochemically formed ceramic coatings to enhance corrosion protection and wear resistance. It serves automotive, aerospace and defense, energy, and general industrial markets. Bodycote plc was founded in 1923 and is headquartered in Macclesfield, the United Kingdom.…
Industry Peers
Specialty Industrial MachineryKey Statistics
About Bodycote (LON: BOY)
›
Bodycote (LON: BOY) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Specialty Industrial Machinery industry, part of the Industrials sector, and reports about 3,841 employees.
The shares were at 919.00 GBp on 20 November 2026, up 49.1% over 52 weeks.
At a market capitalisation of 1.56B GBP, it trades at 27.0 times trailing earnings and 16.2 times forward earnings. The median trailing P/E of its 20 largest Specialty Industrial Machinery peers is 27.6, so BOY is valued in line with them. It pays a dividend yielding 2.54% (it pays out 68% of its earnings), against a median of 1.67% among the dividend payers in that peer group.
Bodycote reports return on equity of 8.6%, an operating margin of 14.8% and revenue up 3.3% year over year.
Its debt exceeds its cash by 190.90M GBP, a debt-to-equity ratio of 0.30. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 5 analysts cover the stock; their mean price target of 925.20 GBp is 0.7% above the current price. The next earnings report is expected on 10 March 2027.